Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 7, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.6K

Cardiolipin-Based Nanoparticles Inhibit α-Synuclein Fibrilization.

Morgan G Stykel1, Justin Medeiros1, Tammy L Ryan2

  • 1Department of Molecular and Cellular Biology, The University of Guelph, Guelph, ON N1G 2W1, Canada.

ACS Chemical Neuroscience
|December 26, 2025
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biosensor for Lyme Disease: Real-time, Specific, and Label-Free Complementary Metal-Oxide-Silicon Transistor Sensing of <i>Borrelia burgdorferi s.l</i>. Outer Surface Protein A in Unprocessed Blood.

ACS sensors·2026
Same author

<i>Etv5</i> Is Required for Peripheral Nerve Function and the Injury Response.

eNeuro·2025
Same author

G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis.

Cell reports·2025
Same author

Network analysis of S-nitrosylated synaptic proteins demonstrates unique roles in health and disease.

Biochimica et biophysica acta. Molecular cell research·2024
Same author

Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy.

Cell death & disease·2024
Same author

Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness.

PloS one·2023

Cardiolipin nanoparticles reverse alpha-synuclein (α-syn) misfolding in synucleinopathies. These nanoparticles dissolve α-syn aggregates, protecting dopamine neurons from cell death and offering a potential therapeutic strategy.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Nanotechnology

Background:

  • Synucleinopathies involve alpha-synuclein (α-syn) misfolding and aggregation.
  • α-syn accumulation forms intracellular inclusions, leading to neuronal death.

Purpose of the Study:

  • Investigate cardiolipin (CL)-based nanoparticles for reversing α-syn fibrillization.
  • Assess the potential of CL-nanoparticles to rescue dopamine neuron loss.

Main Methods:

  • Circular dichroism (CD) and transmission electron microscopy (TEM) analyzed α-syn structural changes.
  • Functional assessments were performed in rodent models of synucleinopathy.

Main Results:

  • CL-nanoparticles induced structural refolding of fibrillar α-syn to an α-helical form.
Keywords:
alpha-synuclein (α-synuclein)cardiolipinlipid nanoparticlesneuronprotein structure

More Related Videos

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.4K
Technique for Intranasal Administration of &#945;-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

960

Related Experiment Videos

Last Updated: Jan 7, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.6K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.4K
Technique for Intranasal Administration of &#945;-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

960
  • Nanoparticles dissolved α-syn aggregates and prevented cell death in models.

    • Conclusions:

    • CL-based nanoparticles demonstrate capacity to mitigate synucleinopathy progression.
    • This approach offers a novel therapeutic avenue for neurodegenerative disorders.